Very little has changed in how Cannabis is delivered. Patients, providers, and consumers are showing a rising demand for safer routes of administration, while achieving proper potency and higher bioavailability. In response to the current deficiencies in the marketplace, GCANRx has developed a product that addresses these unmet needs.
Our biotechnology stems from over a decade of research and development, and has been used in pharmaceutical applications by some of the World’s largest pharmaceutical companies.
GCANRx is setting the bar for improved onset of action, dosing accuracy, enhanced efficacy, and safety in the delivery of cannabinoids.